Actinomyces meyeri isolation from synovial fluid of a patient with metastatic squamous cell lung carcinoma.
Cetin
Emel S
ES
Department of Microbiology and Clinical Microbiology, Suleyman Demirel University, Isparta, Turkey. seslicetin@med.sdu.edu.tr
Kaya
Selcuk
S
Demirci
Mustafa
M
Aridogan
Buket C
BC
D000190:Actinomyces / Q000145:classification*; D000196:Actinomycosis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy; D018570:Risk Assessment; D013582:Synovial Fluid / Q000382:microbiology
D000900:Anti-Bacterial Agents